Each CD includes the full-color, searchable, PDF files of articles and formulations from the Journal.

CD Prices
1 = $95
2 to 5 = $85 each
6 to 9 = $75 each
10 + = $65 each

Library CD
Volume 16, 2012 CD
Six back issues from 2012 on one convenient CD.
Permanent storage and easy retrieval of IJPC articles and formulations.
Only $95 per CD
  • Print journal articles in color from the PDF file for your marketing needs.
  • Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

This CD contains the following articles listed by volume, issue and page number:

Issues Included
Volume/Issue Date Title
Vol. 16 No. 1 January/February 2012 Volume 16, Number 1
Vol. 16 No. 2 March/April 2012 Volume 16, Number 2
Vol. 16 No. 3 May/June 2012 Volume 16, Number 3
Vol. 16 No. 4 July/August 2012 Volume 16, Number 4
Vol. 16 No. 5 September/October 2012 Volume 16, Number 5
Vol. 16 No. 6 November/December 2012 Volume 16, Number 6

Volume 16, 2012 CD ARTICLES

Volume16, 2012 CD ARTICLES
Title (Click for Details) Vol/Issue Page
PreScription: Fifteen Years and Counting Vol. 16 No. 1 4
PreScription: The International Academy of Compounding Pharmacists Remembers Evelyn Timmons, RPh, FIACP, and George Roentsch, RPh, FIACP Vol. 16 No. 1 4
Misinterpretation of United States Pharmacopeia Chapter <797> Vol. 16 No. 1 6
Glutaraldehyde-treated Autologous Pericardium Used in Valve Repairs Vol. 16 No. 1 12
Vitamins: Therapy or Hype Vol. 16 No. 1 17
Oral Mucositis: Etiology and Clinical and Pharmaceutical Management Vol. 16 No. 1 22
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Vol. 16 No. 1 34
Case Studies of Compounded Tramadol Use in Cats Vol. 16 No. 1 44
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Vol. 16 No. 1 50
Institute for Safe Medication Practices Lifetime Achievement Award 2011 Vol. 16 No. 1 54
The ps in Therapeutics Vol. 16 No. 1 58
The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs Vol. 16 No. 1 62
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding–Nonsterile Preparations, Part 4 Vol. 16 No. 1 64
Calculations Vol. 16 No. 1 69
Calcium Chloride 10% Injection Vol. 16 No. 1 70
Calcium Gluconate 10% Injection Vol. 16 No. 1 71
Magnesium Sulfate 10% Injection (0.8 mEq/mL) Vol. 16 No. 1 72
Potassium Acetate 2-mEq/mL and 4-mEq/mL Injections Vol. 16 No. 1 73
Potassium Phosphates Injection Vol. 16 No. 1 74
Sodium Acetate 2-mEq/mL and 4-mEq/mL Injections Vol. 16 No. 1 75
Sodium Bicarbonate 4.2%, 5.0%, 7.5%, and 8.4% Injections Vol. 16 No. 1 76
Sodium Chloride 14.6% and 23.4% Injections Vol. 16 No. 1 77
Sodium Phosphates Injection Vol. 16 No. 1 78
Zinc 1-mg/mL and 5-mg/mL Injections Vol. 16 No. 1 79
Chemical Stability of Pentoxifylline in a Topical Cream Vol. 16 No. 1 80
Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration Vol. 16 No. 1 82
PostScription: Best Practice Recommendations for Compounding 17-Hydroxyprogesterone Vol. 16 No. 1 86
PreScription: Support the Organizations that Support You and Your Practice Vol. 16 No. 2 92
PreScription: Pharmacy Compounding Accreditation Board: A Banner Year, More to Come Vol. 16 No. 2 92
The International Academy of Compounding Pharmacists Stepping Up Efforts to Remedy Problems Caused by the U.S. Drug Enforcement Administration's "Constructive Transfer" Policy Vol. 16 No. 2 94
Brazilian National System for the Monitoring and Improvement of Compounding Practices: Program Outcomes Vol. 16 No. 2 98
Development of a Standardized Intranet Database of Formulation Records for Nonsterile Compounding, Part 2 Vol. 16 No. 2 104
Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy Vol. 16 No. 2 110
Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum Vol. 16 No. 2 117
A Concise Discussion of Headache Types, Part 1 Vol. 16 No. 2 125
Trade Shows: Planning Your Strategy Vol. 16 No. 2 134
Quality Control: 5 Steps to Improve Quality in the Compounding Lab Vol. 16 No. 2 136
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 1 Vol. 16 No. 2 146
Calculations Vol. 16 No. 2 152
Amiodarone Hydrochloride 50-mg/mL Injection Vol. 16 No. 2 154
Bupivacaine Hydrochloride 0.5% with Epinephrine 1:200,000 Injection Vol. 16 No. 2 155
Caffeine Citrate 20-mg/mL Injection Vol. 16 No. 2 156
Chromium 4-mcg/mL Injection Vol. 16 No. 2 157
Furosemide 10-mg/mL Injection Vol. 16 No. 2 158
Glycopyrrolate 0.2-mg/mL Injection Vol. 16 No. 2 159
Labetalol Hydrochloride 5-mg/mL Injection Vol. 16 No. 2 160
Lorazepam 4-mg/mL Injection Vol. 16 No. 2 161
Midazolam 5-mg/mL Injection Vol. 16 No. 2 162
Promethazine Hydrochloride 50-mg/mL Injection Vol. 16 No. 2 163
Stability of Omeprazole in SyrSpend SF Alka (Reconstituted) Vol. 16 No. 2 164
Stability of Vancomycin in SyrSpend SF Vol. 16 No. 2 167
Stability of Acetyl-L-carnitine in 5% Dextrose Using a High-Performance Liquid Chromatography–Mass Spectrometry Times 2 Method Vol. 16 No. 2 170
PostScription: The Importance of Science in the Pharmacy Curriculum Vol. 16 No. 2 174
PreScription: You're On Your Own Vol. 16 No. 3 180
PreScription: Working in Handcuffs Vol. 16 No. 3 180
A Concise Discussion of Headache Types, Part 2: Migraine Vol. 16 No. 3 182
I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Vol. 16 No. 3 190
Burning Mouth Syndrome: A Discussion of a Complex Pathology Vol. 16 No. 3 196
The Student Pharmacist Compounding Competition: Creating Problem Solvers Vol. 16 No. 3 206
Treatment and Prevention of Insect Bites: Mosquitoes Vol. 16 No. 3 210
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Vol. 16 No. 3 220
Marketing: 16 Ways to Incorporate Facebook into Your Compounding Pharmacy Vol. 16 No. 3 224
Quality Control: Analytical Methods: Why Do I Need a Certificate of Analysis? Vol. 16 No. 3 226
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 2: Documentation and Verification Vol. 16 No. 3 230
Calculations Vol. 16 No. 3 236
Acetazolamide 100-mg/mL Injection Vol. 16 No. 3 238
Alfentanil 500-mcg/mL Injection Vol. 16 No. 3 239
Ascorbic Acid 250-mg/mL Injection Vol. 16 No. 3 240
Diltiazem Hydrochloride 5-mg/mL Injection Vol. 16 No. 3 241
Famotidine 10-mg/mL Injection Vol. 16 No. 3 242
Metoclopramide 5-mg/mL Injection Vol. 16 No. 3 243
Naloxone Hydrochloride 1-mg/mL Injection Vol. 16 No. 3 244
Orphenadrine Citrate 30-mg/mL Injection Vol. 16 No. 3 245
Prochlorperazine 5-mg/mL Injection Vol. 16 No. 3 246
Ranitidine 25-mg/mL Injection Vol. 16 No. 3 247
In Vitro Percutaneous Absorption of Ketoprofen and Testosterone: Comparison of Pluronic Lecithin Organogel vs. Pentravan Cream Vol. 16 No. 3 248
Compounding and Dispensing Errors Before and After Implementing Barcode Technology in a Nuclear Pharmacy Vol. 16 No. 3 253
Influence of Temperature on the Thirty-Day Chemical Stability of Extemporaneously Prepared Dexamethasone Paste Vol. 16 No. 3 258
PostScription: Rules for Pharmaceutically Elegant Calculations Vol. 16 No. 3 262
PreScription: Lifelong Learning Vol. 16 No. 4 268
PreScription: Drug Shortages and Discontinued Drugs Vol. 16 No. 4 268
A Concise Discussion of Headache Types, Part 3: Migraine Vol. 16 No. 4 270
Compounding Prokinetic Medications for Companion Animals Vol. 16 No. 4 276
Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide Vol. 16 No. 4 288
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Vol. 16 No. 4 294
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Vol. 16 No. 4 300
Selection of Color Additives: A Regulatory View Vol. 16 No. 4 304
Okay, I've Got It: Now What Do I Do With It? Vol. 16 No. 4 310
Quality Control: Glassware Washers: Cleaning Glassware and Implements Used in Compounding, Part 1 Vol. 16 No. 4 312
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 3: Testing Vol. 16 No. 4 322
Calculations Vol. 16 No. 4 330
Betamethasone 0.6-mg/5-mL Syrup Vol. 16 No. 4 332
Butorphanol Tartrate 2-mg/mL Injection Vol. 16 No. 4 333
Diphenhydramine Hydrochloride 50-mg/mL Injection Vol. 16 No. 4 334
Etomidate 2-mg/mL Injection Vol. 16 No. 4 335
Foscarnet Sodium 24-mg/mL Injection Vol. 16 No. 4 336
Ketorolac Tromethamine 15-mg/mL Injection Vol. 16 No. 4 337
Methyldopate Hydrochloride 50-mg/mL Injection Vol. 16 No. 4 338
Ondansetron Hydrochloride 2-mg/mL Injection Vol. 16 No. 4 339
Sufentanil Citrate 50-mcg/mL Injection Vol. 16 No. 4 340
Tobramycin 40-mg/mL Injection Vol. 16 No. 4 341
Formulation and Stability Evaluation of Extemporaneously Prepared Atenolol Capsules from Crushed Atenolol Tablets Vol. 16 No. 4 342
Stability of Gabapentin in SyrSpend SF Vol. 16 No. 4 347
PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare Vol. 16 No. 4 350
PreScription: What Is Involved in the Making of Remington's? Vol. 16 No. 5 356
Remington: The Science and Practice of Pharmacy: From the Past into the Future Vol. 16 No. 5 358
Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report Vol. 16 No. 5 364
Medical Therapy for Acquired Urinary Incontinence in Dogs Vol. 16 No. 5 369
Bioidentical Thyroid Replacement Therapy in Practice: Delivering a Physiologic T4-T3 Ratio for Improved Patient Outcomes with the Listecki-Snyder Protocol Vol. 16 No. 5 376
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Vol. 16 No. 5 382
Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies Vol. 16 No. 5 386
Marketing: Drug Shortages and Discontinued Drugs: Marketing Techniques that Compounding Pharmacists Can Use to Advise and Serve Their Patients Vol. 16 No. 5 394
Quality Control: Glassware Washers: Cleaning Glassware and Implements Used in Compounding, Part 2 Vol. 16 No. 5 396
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 4: Cleaning and Packaging Vol. 16 No. 5 405
Calculations Vol. 16 No. 5 416
Doxapram Hydrochloride 20-mg/mL injection Vol. 16 No. 5 418
Enalaprilat 1.25-mg/mL Injection Vol. 16 No. 5 419
Esmolol Hydrochloride 10-mg/mL Injection Vol. 16 No. 5 420
Fluconazole 2-mg/mL Injection Vol. 16 No. 5 421
Haloperidol 50-mg/mL in Oil Injection Vol. 16 No. 5 422
Meperidine Hydrochloride 50-mg/mL Injection Vol. 16 No. 5 423
Methocarbamol 100-mg/mL Injection Vol. 16 No. 5 424
Metronidazole 5-mg/mL Injection Vol. 16 No. 5 425
Nalbuphine Hydrochloride 10-mg/mL Injection Vol. 16 No. 5 426
Oxymorphone Hydrochloride 1-mg/mL Injection Vol. 16 No. 5 427
Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date Vol. 16 No. 5 428
Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time Vol. 16 No. 5 431
Compounding of Slow-release Niacinamide Capsules: Feasibility and Characterization Vol. 16 No. 5 434
PostScription: Remington Twenty-Second Edition Vol. 16 No. 5 438
PreScription: A Degree in Pharmacy: How Valuable! Vol. 16 No. 6 444
The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act Vol. 16 No. 6 446
Palliative Care and Compounding for Household Pets Vol. 16 No. 6 452
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Vol. 16 No. 6 456
Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents Vol. 16 No. 6 462
Beyond-use Date: Establishment and Maintenance Vol. 16 No. 6 471
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Vol. 16 No. 6 476
Colds and Cough Vol. 16 No. 6 480
Marketing: Overcoming Objections to Prescribing Compounded Medications Vol. 16 No. 6 484
Quality Control: Analytical Methods. Certificates of Analysis, Part 1 Vol. 16 No. 6 486
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 5: Outsourcing and Responsible Personnel Vol. 16 No. 6 490
Calculations Vol. 16 No. 6 498
Aminophylline 25-mg/mL Injection Vol. 16 No. 6 500
Ammonium Chloride 5-mEq/mL Injection Vol. 16 No. 6 501
Azathioprine 10-mg/mL Injection Vol. 16 No. 6 502
Copper 0.4-mg/mL Injection Vol. 16 No. 6 503
Dipyridamole 5-mg/mL Injection Vol. 16 No. 6 504
Dopamine Hydrochloride 80-mg/mL Injection Vol. 16 No. 6 505
Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules Vol. 16 No. 6 506
Papaverine Hydrochloride 30-mg/mL Injection Vol. 16 No. 6 507
Valproate Sodium 100-mg/mL Injection Vol. 16 No. 6 508
Vercuronium Bromide 1-mg/mL Injection Vol. 16 No. 6 509
Stability of Ursodiol in SyrSpend SF Cherry Flavored Vol. 16 No. 6 510
Stability of Propranolol Hydrochloride in SyrSpend SF Vol. 16 No. 6 513
Rice Bran Oil: Preparation and Evaluation of Novel Liquisolid and Semisolid Formulations Vol. 16 No. 6 516
PostScription: Center for Compounding Practice and Research Underway at Virginia Commonwealth University School of Pharmacy Vol. 16 No. 6 524